Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects

  • Authors:
    • Jinbao Zong
    • Qinglin Peng
    • Qingyong Wang
    • Ting Zhang
    • Dongsheng Fan
    • Xuemei Xu
  • View Affiliations

  • Published online on: October 1, 2009     https://doi.org/10.3892/or_00000522
  • Pages: 953-961
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Cervical cancer is one of the most common cancers in women worldwide and persistent infection with human papilloma virus (HPV)s is considered to be the major risk factor. Millions of women are currently infected with high risk genotypes. Therefore, it is imperative to develop therapeutic vaccines to eliminate established infection or HPV-related disease. In the current study, we generated two potential therapeutic HPV DNA vaccines, SigmE7/MtHSP70 and SigmE7/HuHSP70, using human and mycobacterium tuberculosis HSP70 linked, respectively, to HPV16 mE7 and the signal peptide gene of human CD33. Our comparative evaluation of these two vaccines found that vaccination with the SigmE7/HuHSP70 DNA vaccine induced a stronger E7-specific CD8+ T cell immune response and resulted in a more significant therapeutic effect against E7 expressing tumor cells. Our study may serve as an important foundation and significant reference for future clinical applications.

Related Articles

Journal Cover

October 2009
Volume 22 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zong J, Peng Q, Wang Q, Zhang T, Fan D and Xu X: Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects. Oncol Rep 22: 953-961, 2009.
APA
Zong, J., Peng, Q., Wang, Q., Zhang, T., Fan, D., & Xu, X. (2009). Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects. Oncology Reports, 22, 953-961. https://doi.org/10.3892/or_00000522
MLA
Zong, J., Peng, Q., Wang, Q., Zhang, T., Fan, D., Xu, X."Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects". Oncology Reports 22.4 (2009): 953-961.
Chicago
Zong, J., Peng, Q., Wang, Q., Zhang, T., Fan, D., Xu, X."Human HSP70 and modified HPV16 E7 fusion DNA vaccine induces enhanced specific CD8+ T cell responses and anti-tumor effects". Oncology Reports 22, no. 4 (2009): 953-961. https://doi.org/10.3892/or_00000522